Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: margie who wrote (5457)	10/5/1998 7:13:00 PM
From: nord	Read Replies (1) of 6136

Margie Couldn't agree more. Why be taken out now? Why spin off oncology side? The company is a cash cow. They were given new drugs for next to nothing the drug screening platform and the new drug pipeline aren't figured into current valuation even at rebounded price imo. The sales of Viracept non script wholesale accounts for 40% and is not included in weekly/ monthly script data. The growth in wholesale market hospitals hmo etc is even faster than the retail. In addition we haven't gotten a handle on how big the drug combo with sustiva and potentially imnr will be. Seems to me the right time to buy stock and put in away with the rest. Why sell now? Unless of course they do have some kinda offer than even the more patient might consider. Regards Norden

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next